CRNX icon

Crinetics Pharmaceuticals

221 hedge funds and large institutions have $3.01B invested in Crinetics Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 96 increasing their positions, 64 reducing their positions, and 37 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
221
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.14M
Puts
$428K
Net Calls
Net Calls Change

Top Buyers

1 +$35.1M
2 +$17.7M
3 +$13.8M
4
RI
RTW Investments
New York
+$13.4M
5
Goldman Sachs
Goldman Sachs
New York
+$11.5M
Name Holding Trade Value Shares
Change
Change in
Stake
PFBT
201
Parkside Financial Bank & Trust
Missouri
$1.35K
PWMG
202
Private Wealth Management Group
New Jersey
$1.29K
LFG
203
Larson Financial Group
Missouri
$1.26K
BIG
204
Brooklyn Investment Group
New York
$1.06K
CIA
205
Cape Investment Advisory
Georgia
$892
WTC
206
WhitTier Trust Company
Nevada
$862
SO
207
Sierra Ocean
California
$834
Jones Financial Companies
208
Jones Financial Companies
Missouri
$809
WB
209
Webster Bank
Connecticut
$805
WSFS
210
Wilmington Savings Fund Society
Delaware
$575
PPC
211
Park Place Capital
Alabama
$512
BFS
212
Bare Financial Services
Pennsylvania
$460
JSAM
213
J. Safra Asset Management
New York
$419
TWD
214
True Wealth Design
Ohio
$374
CSS
215
Cubist Systematic Strategies
Connecticut
$374
BIA
216
Bell Investment Advisors
California
$288
TPWA
217
Twin Peaks Wealth Advisors
California
$171
CPG
218
Cornerstone Planning Group
New Jersey
$117
CIAM
219
Caitong International Asset Management
Hong Kong
$29
LGM
220
Logos Global Management
California
IHAM
221
Integral Health Asset Management
New York
CM
222
Caption Management
Oklahoma
Principal Financial Group
223
Principal Financial Group
Iowa
SVCM
224
Saturn V Capital Management
Texas
Macquarie Group
225
Macquarie Group
Australia